Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Savannah › NPI 1407022908
NP / PA

First Family Medical LLC

First Family Medical LLC was paid $579K by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.

33Billing provider infoFIRST FAMILY MEDICAL LLC
SAVANNAH, TN 38372
33aNPI1407022908assigned 05/05/2008
28Total paid$579K
24GClaims28,885
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Family Nurse Practitioner providers in Tennessee

Rank by total paid#28 of 687
Median peer was paid$15K
This provider vs. median40×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20183,679$95K
20194,164$102K
20202,106$49K
20215,483$87K
20225,743$96K
20234,728$84K
2024incomplete2,982$65K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 41% 6,973 5,202 $240K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 30% 3,641 2,597 $174K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 9.6% 4,277 3,136 $56K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 5.3% 1,029 905 $31K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 4.1% 2,201 1,837 $23K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4.0% 1,112 930 $23K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2.0% 444 395 $12K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 92 82 $4K
92552 <1% 252 212 $3K
99401 <1% 237 189 $2K
96127 <1% 478 425 $2K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 19 13 $1K
14 more codes
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 65 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,459 $997.19
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,661 $975.81
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 86 $850.00
99406 <1% 119 $778.36
36415 Collection of venous blood by venipuncture <1% 575 $773.13
99173 <1% 253 $762.04
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 743 $517.55
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 12 $281.52
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 197 $173.96
87807 <1% 16 $173.05
81003 <1% 63 $86.10
1036F 0% 25 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 1,856 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARBURY, LISA (OWNER)